Next-Gen Biologicals: Storage Solutions
Assessing the impact of cryo-storage breakthroughs on the decentralized clinical trial model of the future.
The future of medicine is biological. As the industry shifts toward personalized therapeutics, the requirements for storage are becoming increasingly specialized.
Our 'Cryo-Vault' initiative is pioneering the use of liquid nitrogen cooling systems that maintain stability at -196°C. This infrastructure is essential for the emerging decentralized trial model, allowing us to deliver high-value biologicals to remote clinical sites without sacrificing potency or safety.
Our 'Cryo-Vault' initiative is pioneering the use of liquid nitrogen cooling systems that maintain stability at -196°C. This infrastructure is essential for the emerging decentralized trial model, allowing us to deliver high-value biologicals to remote clinical sites without sacrificing potency or safety.
